Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,414Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Nubeqa

PharmaCompass

01

Brand Name : Nubeqa

Darolutamide

arrow
Simposio AFI
Not Confirmed

Brand Name : Nubeqa

arrow
Simposio AFI
Not Confirmed

Darolutamide

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 489

2021 Revenue in Millions : 241

Growth (%) : 103

blank

02

Brand Name : Nubeqa

Darolutamide

arrow
Simposio AFI
Not Confirmed

Brand Name : Nubeqa

arrow
Simposio AFI
Not Confirmed

Darolutamide

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 943

2022 Revenue in Millions : 489

Growth (%) : 86

blank

03

Brand Name : Nubeqa

Darolutamide

arrow
Simposio AFI
Not Confirmed

Brand Name : Nubeqa

arrow
Simposio AFI
Not Confirmed

Darolutamide

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 1,604

2023 Revenue in Millions : 943

Growth (%) : 70

blank